SSRP1 and neoplasm: FACT subunits were shown to be overexpressed in breast cancer and pharmacological entrapment of FACT within chromatin—which reduced FACT activity—had positive (dose-dependent) effects on murine survival, prevented tumor onset and delayed progression in vivo (183).